The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunelm Regulatory News (DNLM)

Share Price Information for Dunelm (DNLM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,129.00
Bid: 1,096.00
Ask: 1,095.00
Change: 39.00 (3.58%)
Spread: -1.00 (-0.091%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,090.00
DNLM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

B/C SHARE SCHEME - RESULTS OF ELECTIONS

19 Nov 2012 09:00

RNS Number : 4242R
Dunelm Group plc
19 November 2012
 



 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, NEW ZEALAND, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

 

Dunelm Group plc

 

(the 'Company')

 

19 November 2012

 

B/C SHARE SCHEME - RESULTS OF ELECTIONS, B SHARE DIVIDEND AND UPDATE ON B/C SHARE SCHEME

 

 

Following the approval by Shareholders of the B/C Share Scheme at the General Meeting of the Company held on 16 November 2012, the Company today provides an update in respect of the B/C Share Scheme.

 

Results of elections

 

As at the Election Deadline of 4.30 p.m. on 16 November 2012, Shareholders' elections or, as the case may be, deemed elections for the Share Alternatives in respect of the B/C Share Scheme were as follows:

 

Number of Ordinary Shares

Income Option

117,620,890

 

Capital Option

84,971,750

TOTAL

202,592,640

 

 

Shareholders who have not made a valid election, and all Overseas Shareholders with a registered address in a Restricted Territory, have been deemed to have elected for the Income Option in respect of all of their Ordinary Shares.

 

Based on Shareholders' elections or, as the case may be, deemed elections for the Share Alternatives set out above,117,620,890 B Shares of 0.001 pence each and 84,971,750 C Shares of 0.001 pence each were allotted and issued at 8.00 a.m. today, split between the Share Alternatives as follows:

 

 

Number of B Shares and C Shares

Income

Option

117,620,890 B Shares

Capital

Option

84,971,750 C Shares

TOTAL

202,592,640 shares comprising

117,620,890 B Shares and 84,971,750 C Shares

 

 

 

No application has been, or will be, made for the B Shares or the C Shares or the resulting Deferred Shares to be admitted to listing on the Official List or admitted to trading on the London Stock Exchange's main market for listed securities, nor will the B Shares or the C Shares or the Deferred Shares be listed or admitted to trading on any other recognised investment exchange.

 

No share certificates will be issued in respect of the B Shares or the C Shares or the Deferred Shares and no CREST accounts will be credited with such shares.

 

 

B Share Dividend - the Income Option

 

The B Share Dividend of 32.5 pence per B Share issued pursuant to the Income Option is today declared and the B Shares issued pursuant to the Income Option have today been automatically converted into Deferred Shares having negligible value and carrying extremely limited rights.

 

It is expected that Shareholders entitled to receive the B Share Dividend will be sent cheques or, if mandate instructions are held in respect of a Sterling bank account, that payments will be made by BACS to mandated accounts in respect of the B Share Dividend by 30 November 2012.

 

 

Next events

 

It is further expected that on 20 November 2012, UBS Limited, acting as principal (and not as agent, nominee, or trustee), will make the Purchase Offer in respect of C Shares issued pursuant to the

Capital Option by way of an announcement through a Regulatory Information Service.

 

Unless the context otherwise requires, capitalised terms used in this announcement shall have the same meaning ascribed to them in the circular published by the Company on 15 October 2012 in relation to the B/C Share Scheme. The circular is available in the investor section of the Company's website at www.dunelm-mill.com.

 

All references in this announcement to times are to London times unless otherwise stated.

 

It should be noted that no prospectus is required, in accordance with the prospective directive (Directive 2003/71/EC), to be published in connection with the issue of B and C Shares.

 

Enquiries:

 

 

Dunelm Group plc 0116 2644 356

Nick Wharton, Chief Executive

David Stead, Finance Director

MHP Communications 020 3128 8100

John Olsen

Simon Hockridge

Naomi Lane

 

This announcement does not constitute an offer to sell or the solicitation of an offer to buy any security, nor shall there be any sale, issuance or transfer of the securities referred to in any jurisdiction in contravention of applicable law.

 

None of the B Shares, the C Shares or the Deferred Shares have been or will be registered under the US Securities Act or the state securities laws of the United States and none of them may be offered or sold in the United States unless pursuant to a transaction which has been registered under the US Securities Act and/or relevant state securities laws or which is not subject to the registration requirements of the US Securities Act or such laws, either because of an exemption therefrom or otherwise.

 

None of the B Shares, the C Shares or the Deferred Shares or this announcement or the Circular has been approved, disapproved or otherwise recommended by any US federal or state securities commission or other regulatory authority or any non-US securities commission or regulatory authority nor have any such authorities confirmed the accuracy or determined the adequacy of this announcement or the Circular. Any representation to the contrary is a criminal offence in the United States.

 

Apart from the responsibilities and liabilities, if any, which may be imposed on UBS Limited by the FSMA or the regulatory regime established thereunder, UBS Limited accepts no responsibility or liability whatsoever for the contents of this announcement or the Circular or for any other statement made or purported to be made in connection with the Company or the proposed Return of Capital. UBS Limited accordingly disclaims all and any responsibility or liability whether arising in tort, contract or otherwise (save as referred to above) which it might otherwise have in respect of this announcement, the Circular or any such statement.

 

This announcement has been issued by, and is the sole responsibility of, the Company.

 

Name of authorised Company official responsible for making this notification:

 

Dawn Durrant, Company Secretary

 

 

 

END

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCVKLBFLFFEFBF
Date   Source Headline
15th Jul 20207:00 amRNSFourth Quarter Trading Update
30th Jun 20207:00 amRNSTotal Voting Rights
29th Jun 202010:15 amRNSHolding(s) in Company
15th Jun 202012:40 pmRNSHolding(s) in Company
9th Jun 20201:15 pmRNSHolding(s) in Company
29th May 20207:00 amRNSTotal Voting Rights
21st May 202012:23 pmRNSHolding(s) in Company
30th Apr 20207:00 amRNSTotal Voting Rights
16th Apr 20207:00 amRNSBusiness and liquidity update
7th Apr 20207:00 amRNSBlock listing Interim Review
7th Apr 20207:00 amRNSBlock listing Interim Review
7th Apr 20207:00 amRNSBlock listing Interim Review
7th Apr 20207:00 amRNSBlock listing Interim Review
31st Mar 20207:00 amRNSTotal Voting Rights
24th Mar 20207:00 amRNSUpdate on current trading and Coronavirus
17th Mar 20207:00 amRNSDirector/PDMR Shareholding
10th Mar 20207:00 amRNSDirector/PDMR Shareholding
4th Mar 20207:00 amRNSDirector/PDMR Shareholding
28th Feb 202012:45 pmRNSTotal Voting Rights
12th Feb 20205:41 pmRNSHolding(s) in Company
12th Feb 20207:00 amRNSInterim Results
31st Jan 20207:00 amRNSTotal Voting Rights
9th Jan 20207:00 amRNSSecond Quarter Trading Update
2nd Jan 202011:05 amRNSHolding(s) in Company
31st Dec 20197:00 amRNSTotal Voting Rights
17th Dec 20199:00 amRNSHolding(s) in Company
10th Dec 20197:00 amRNSAppointment of joint corporate broker
5th Dec 20198:20 amRNSHolding(s) in Company
5th Dec 20197:00 amRNSTrading Update
29th Nov 20197:00 amRNSTotal Voting Rights
19th Nov 20192:25 pmRNSDirectorate Change
19th Nov 20192:25 pmRNSResult of AGM
15th Nov 20193:10 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSSharesave option granted to Laura Carr
31st Oct 20197:00 amRNSTotal Voting Rights
22nd Oct 20197:00 amRNSBlock listing Interim Review
22nd Oct 20197:00 amRNSBlock listing Interim Review
22nd Oct 20197:00 amRNSBlock listing Interim Review
22nd Oct 20197:00 amRNSBlock listing Interim Review
17th Oct 20199:45 amRNSHolding(s) in Company
17th Oct 20197:00 amRNSDirector/PDMR Shareholding
15th Oct 20195:20 pmRNSHolding(s) in Company
10th Oct 20197:00 amRNSFirst Quarter Trading Update
9th Oct 20197:00 amRNSAnnual Financial Report
27th Sep 20197:00 amRNSTotal Voting Rights
6th Sep 20197:00 amRNSDirector/PDMR Shareholding
4th Sep 20197:00 amRNSDirectorate Change
4th Sep 20197:00 amRNSFinal Results
30th Aug 20197:00 amRNSTotal Voting Rights
1st Aug 20197:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.